MARC보기
LDR00000nam u2200205 4500
001000000436548
00520200228144624
008200131s2019 ||||||||||||||||| ||eng d
020 ▼a 9781088320310
035 ▼a (MiAaPQ)AAI13809643
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 247004
0820 ▼a 616
1001 ▼a Shyer, Justin Andrew.
24510 ▼a Targeted Genetic Screens Identify Metabolic Regulators of T Helper Cell Differentiation and Function.
260 ▼a [S.l.]: ▼b Yale University., ▼c 2019.
260 1 ▼a Ann Arbor: ▼b ProQuest Dissertations & Theses, ▼c 2019.
300 ▼a 130 p.
500 ▼a Source: Dissertations Abstracts International, Volume: 81-03, Section: B.
500 ▼a Advisor: Craft, Joseph E.
5021 ▼a Thesis (Ph.D.)--Yale University, 2019.
506 ▼a This item must not be sold to any third party vendors.
506 ▼a This item must not be added to any third party search indexes.
520 ▼a Upon activation, CD4 T cells exhibit changes in cellular metabolism required to meet the bioenergetic, biosynthetic, and functional demands of an effector T cell. Activating signals, including TCR crosslinking, co-stimulation, and cytokine signaling converge on master metabolic regulators whose activity orchestrate cellular biochemistry. Unlike their naive counterparts, activated CD4 T cells engage a program of anabolism, favoring the production of substrates required for cell division and remodeling over more efficient cellular bioenergetic processes. This anabolic program is an absolute requirement for the activation of CD4 T cells, but how the cellular biochemical state regulates CD4 T cell activation processes is incompletely understood.Herein, I first present a broad introduction to CD4 T cell activation and metabolism in Chapter 1. In chapter 2, I describe the development and validation of multiple novel tools for conducting CRISPR/Cas9 screens in primary murine cells. I describe the application of these tools in Chapter 3, in which I present the results of a metabolic gene targeted CRISPR/Cas9 screen conducted in murine primary Th1 cells in vitro. I describe both the success of the screen in identifying known metabolic regulators of Th1 cell activation, as well as the novel discovery that the citrate acid (TCA) cycle and components of the electron transport chain (ETC) are required for Ifng transcription in our model. This discovery is further explored in Chapter 4, in which we use genetic, pharmacologic, and metabolomic approaches to demonstrate that early Th cell differentiation processes, including proliferation and epigenetic remodeling, are uncoupled from late Th cell effector function by TCA cycle metabolite utilization. I describe our finding that early in activation, Th1 cells require a set of mitochondrial transporters to shuttle metabolites, including citrate and aspartate, from the mitochondria for consumption in the cytoplasm to promote cell division and epigenetic remodeling. This is opposed to cells late in activation, which require the activity of Complex II of the ETC (succinate dehydrogenase
590 ▼a School code: 0265.
650 4 ▼a Immunology.
690 ▼a 0982
71020 ▼a Yale University. ▼b Immunobiology.
7730 ▼t Dissertations Abstracts International ▼g 81-03B.
773 ▼t Dissertation Abstract International
790 ▼a 0265
791 ▼a Ph.D.
792 ▼a 2019
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T15490605 ▼n KERIS ▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다.
980 ▼a 202002 ▼f 2020
990 ▼a ***1816162
991 ▼a E-BOOK